Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC.
Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL. Crandall JP, et al. Among authors: esposito g. EJNMMI Res. 2017 Dec;7(1):8. doi: 10.1186/s13550-017-0258-3. Epub 2017 Jan 19. EJNMMI Res. 2017. PMID: 28102506 Free PMC article.
Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.
Collins BT, Vahdat S, Erickson K, Collins SP, Suy S, Yu X, Zhang Y, Subramaniam D, Reichner CA, Sarikaya I, Esposito G, Yousefi S, Jamis-Dow C, Banovac F, Anderson ED. Collins BT, et al. Among authors: esposito g. J Hematol Oncol. 2009 Jan 17;2:1. doi: 10.1186/1756-8722-2-1. J Hematol Oncol. 2009. PMID: 19149899 Free PMC article. Clinical Trial.
CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT. Vahdat S, et al. Among authors: esposito g. J Hematol Oncol. 2010 Feb 4;3:6. doi: 10.1186/1756-8722-3-6. J Hematol Oncol. 2010. PMID: 20132557 Free PMC article. Clinical Trial.
Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy.
Carrasquilla M, Creswell ML, Pepin AN, Wang E, Forsthoefel M, McGunigal M, Bullock E, Lei S, Collins BT, Lischalk JW, Esposito G, Aghdam N, Kumar D, Suy S, Leger P, Hankins RA, Dawson NA, Collins SP. Carrasquilla M, et al. Among authors: esposito g. Front Oncol. 2021 Jan 18;10:606260. doi: 10.3389/fonc.2020.606260. eCollection 2020. Front Oncol. 2021. PMID: 33537236 Free PMC article. Review.
2,378 results